z-logo
open-access-imgOpen Access
Identification of new octamer transcription factor 1‐target genes upregulated in castration‐resistant prostate cancer
Author(s) -
Yamamoto Shinichiro,
Takayama Kenichi,
Obinata Daisuke,
Fujiwara Kyoko,
Ashikari Daisaku,
Takahashi Satoru,
Inoue Satoshi
Publication year - 2019
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.14183
Subject(s) - prostate cancer , gene knockdown , cancer research , transcription factor , biology , androgen receptor , gene , cancer , downregulation and upregulation , cancer cell , protein subunit , genetics
Octamer transcription factor 1 ( OCT 1) is an androgen receptor ( AR )‐interacting partner and regulates the expression of target genes in prostate cancer cells. However, the function of OCT 1 in castration‐resistant prostate cancer ( CRPC ) is not fully understood. In the present study, we used 22Rv1 cells as AR ‐positive CRPC model cells to analyze the role of OCT 1 in CRPC . We showed that OCT 1 knockdown suppressed cell proliferation and migration of 22Rv1 cells. Using microarray analysis, we identified four AR and OCT 1‐target genes, disks large‐associated protein 5 ( DLGAP 5), kinesin family member 15 ( KIF 15), non‐ SMC condensin I complex subunit G ( NCAPG ), and NDC 80 kinetochore complex component ( NUF 2) in 22Rv1 cells. We observed that knockdown of DLGAP 5 and NUF 2 suppresses growth and migration of 22Rv1 cells. Furthermore, immunohistochemical analysis showed that positive expression of DLGAP 5 in prostate cancer specimens is related to poor cancer‐specific survival rates of patients. Notably, enhanced expression of DLGAP 5 was observed in CRPC tissues of patients. Thus, our findings suggest that these four genes regulated by the AR / OCT 1 complex could have an important role in CRPC progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here